New guidelines for SARS-CoV-2 genomic surveillance aim to standardize NGS practices
nRichDX to unveil advanced liquid biopsy solutions at AMP 2024, showcasing high-yield sample prep innovations to enhance sensitivity in oncology diagnostics
QuantiFERON-TB Gold Plus remains crucial for the detection of latent tuberculosis infection, aiding in breaking the cycle of disease transmission
New social media channels will better serve the clinical community by making it even easier to stay up to date
Germline sequencing provides crucial insights into clonal hematopoiesis mutations with the potential to improve cancer patient outcomes and new oncology therapy development
Brand new event designed to bring together everyone working in the clinical laboratory science industry
Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice
Explore the modern point-of-care ecosystem and its impact on healthcare delivery
Roche four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and RSV receives U.S. FDA Emergency Use Authorization
An introduction to the challenges and considerations for clinical labs embarking on digital transformation in healthcare
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways
SelectScience clinical webinars can be added to HCPC and IBMS portfolios as evidence of CPD
Partnership aims to expand CE-IVD molecular assay offerings
Discover the human side of laboratory medicine with our #Lab4Life editorial feature
Discover the latest technology to supercharge your gene therapy vector analysis workflow
New device rapidly isolates blood plasma for diagnostics and precision medicine
Cologuard Plus was evaluated against an independent fecal immunochemical test, which it significantly outperformed
The Tumor Tissue Modified Viral (TTMV)-HPV DNA blood test aids in the detection of HPV-driven cancer
Study shows blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90%
Collaboration aims to expand optimal genetic testing for individual diseases
A new test diagnoses patients with melioidosis within hours, rather than days, meaning they can receive the correct antibiotics faster
David Wells, CEO of the IBMS, discusses the Institute’s plans to ensure the future of biomedical science careers
New collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions
In this guest editorial, discover how Capitainer® DBS cards with qDBS technology enable easy self-sampling with precision and accuracy
